BETA

7 Amendments of Clara PONSATÍ OBIOLS related to 2020/0322(COD)

Amendment 12 #
Proposal for a regulation
Recital 2
(2) In light of the lessons learnt during the ongoing COVID-19 pandemic and in order to facilitate adequate Union-wide preparedness and response to all cross- border threats to health, the legal framework for epidemiological surveillance, monitoring, early warning of, and combating serious cross-border threats to health, as set out in Decision No 1082/2013/EU, needs to be broadened with regard to additional reporting requirements and analysis on health systems indicators, and cooperation by Member States with the European Centre for Disease Prevention and Control (ECDC). Moreover, in order to ensure effective Union response to novel cross- border threats to health, the legal framework to combat serious cross-border threats to health should enable to immediately adopt case definitions for the surveillance of novel threats and should provide for the establishment of a network of EU reference laboratories and a network to support monitoring of disease outbreaks that are relevant to substances of human origin. The capacity for contact tracing should be strengthened via the creation of an automated system, using modern technologies. Further learning on the lessons from the COVID-19 pandemic, the legal framework should set the basis to ensure supply chain resilience of critical medicines.
2021/04/21
Committee: IMCO
Amendment 149 #
Proposal for a regulation
Article 13 – paragraph 1
1. The network for the epidemiological surveillance of the communicable diseases and of the related special health issues referred to in points (i) and (ii) of point (a) of Article 2(1) shall ensure a permanent communication between the Commission, the ECDC, and the competent authorities responsible at national, and where applicable regional, level for epidemiological surveillance.
2021/04/21
Committee: IMCO
Amendment 150 #
Proposal for a regulation
Article 13 – paragraph 2 – point c
(c) contribute to the evaluation and monitoring of communicable disease prevention and control programmes in order to provide the evidence for recommendations to strengthen and improve those programmes at the regional, national and Union level;
2021/04/21
Committee: IMCO
Amendment 151 #
Proposal for a regulation
Article 13 – paragraph 2 – point i a (new)
(ia) make mitigation plans containing preventative measures that help ensure the continued supply of critical medicines, such as diversification of supply chains, as well as including production and supply capacity;
2021/04/21
Committee: IMCO
Amendment 152 #
Proposal for a regulation
Article 13 – paragraph 3 – introductory part
3. The national and regional competent authorities referred to in paragraph 1 shall communicate the following information to the participating authorities of the epidemiological surveillance network:
2021/04/21
Committee: IMCO
Amendment 153 #
Proposal for a regulation
Article 13 – paragraph 3 – point f
(f) information about contract tracing monitoring systems developed at national and regional level.
2021/04/21
Committee: IMCO
Amendment 154 #
Proposal for a regulation
Article 13 – paragraph 4
4. When reporting information on epidemiological surveillance, the national and regional competent authorities shall, where available, use the case definitions adopted in accordance with paragraph 9 for each communicable disease and related special health issue referred to in paragraph 1.
2021/04/21
Committee: IMCO